C. Tuttle

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

J. Bartlett, R. Lewis, T. Flynn, 1991 .

Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.

Paul E. Méndez, R. Haubrich, R. Brookmeyer, 1997, American journal of ophthalmology.

Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.

Paul E. Méndez, R. Haubrich, J. Phair, 1995, Archives of internal medicine.

Detection of the mutated K-Ras biomarker in colorectal carcinoma.

J. Costa, B. Doolittle, C. Tuttle, 2001, Experimental and molecular pathology.

Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).

J. Bartlett, R. Lewis, T. Flynn, 1992, Controlled clinical trials.

Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: The foscarnet-ganciclovir cytomegalovirus retinitis trial

Paul E. Méndez, R. Haubrich, A. Friedman, 1997 .